Fosamprenavir sodium

This classification denotes an enzyme inhibitor with the molecular formula C25H34N3O9PS.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XSG28FSA0W, chemically known as carbamic acid, ((1s,2r)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, c-((3s)-tetrahydro-3-furanyl) ester, disodium salt but more generally known as fosamprenavir sodium, which bears US NIH Compound Identifier 131537. Most nations, for tariff and trade purposes, schedule fosamprenavir sodium under HS 29350090 and SITC 51580. As of Q4 2014, FOSAMPRENAVIR SODIUM remains US FDA's Preferred Term for this commodity. Fosamprenavir sodium bears US NLM identifiers UMLS ID C1366241 and NCI Concept Code C72786. SMILES: CC(C)CN(C[C@H]([C@H](CC1CCCCC1)NC(=O)O[C@H]2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3CCC(CC3)N.[NA+].[NA+].